Low doses of Paclitaxel repress breast cancer invasion through DJ-1/KLF17 signalling pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low doses of Paclitaxel repress breast cancer invasion through DJ-1/KLF17 signalling pathway
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-04-27
DOI
10.1111/1440-1681.12960
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Free paclitaxel-loaded E-selectin binding peptide modified micelle self-assembled from hyaluronic acid-paclitaxel conjugate inhibit breast cancer metastasis in a murine model
- (2017) Xiaofeng Han et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Inhibition of breast cancer metastasis by paclitaxel-loaded pH responsive poly(β-amino ester) copolymer micelles
- (2017) Yanjun Chen et al. Nanomedicine
- DJ-1 as a potential biomarker for the early diagnosis in lung cancer patients
- (2017) Binbin Han et al. TUMOR BIOLOGY
- Low doses of paclitaxel enhance liver metastasis of breast cancer cells in the mouse model
- (2016) Qi Li et al. FEBS Journal
- Blood viscosity as a sensitive indicator for paclitaxel induced oxidative stress in human whole blood
- (2015) Gamaleldin I. Harisa SAUDI PHARMACEUTICAL JOURNAL
- Synergy of Nab-paclitaxel and Bevacizumab in Eradicating Large Orthotopic Breast Tumors and Preexisting Metastases
- (2015) Lisa D. Volk et al. NEOPLASIA
- DJ-1 upregulates breast cancer cell invasion by repressing KLF17 expression
- (2014) I A Ismail et al. BRITISH JOURNAL OF CANCER
- Paclitaxel Therapy Promotes Breast Cancer Metastasis in a TLR4-Dependent Manner
- (2014) L. Volk-Draper et al. CANCER RESEARCH
- DJ-1: a promising marker in metastatic uveal melanoma
- (2014) Li-Li Chen et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- How Taxol/paclitaxel kills cancer cells
- (2014) Beth A. Weaver MOLECULAR BIOLOGY OF THE CELL
- Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles
- (2014) L. M. Zasadil et al. Science Translational Medicine
- DJ-1 is activated in medulloblastoma and is associated with cell proliferation and differentiation
- (2014) Jia-ping Lin et al. World Journal of Surgical Oncology
- 2-Hydroxycinnamaldehyde inhibits the epithelial-mesenchymal transition in breast cancer cells
- (2013) Ismail Ahmed Ismail et al. BREAST CANCER RESEARCH AND TREATMENT
- Different administration strategies with paclitaxel induce distinct phenotypes of multidrug resistance in breast cancer cells
- (2013) Donghai Jiang et al. CANCER LETTERS
- Expression of DJ-1 in Endometrial Cancer
- (2013) Kuanyong Shu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Differential Effects of Drugs Targeting Cancer Stem Cell (CSC) and Non-CSC Populations on Lung Primary Tumors and Metastasis
- (2013) Leyre Larzabal et al. PLoS One
- Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breast
- (2012) Benio Tsuchiya et al. HISTOPATHOLOGY
- DJ-1 may contribute to metastasis of non-small cell lung cancer
- (2011) Jing Bai et al. MOLECULAR BIOLOGY REPORTS
- Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-κB in Breast Cancer Cells and Potentiates the Growth Inhibitory Effect of Paclitaxel in a Breast Cancer Nude Mice Model
- (2009) Hee Joon Kang et al. Breast Journal
- KLF17 is a negative regulator of epithelial–mesenchymal transition and metastasis in breast cancer
- (2009) Kiranmai Gumireddy et al. NATURE CELL BIOLOGY
- Non-anti-mitotic concentrations of taxol reduce breast cancer cell invasiveness
- (2008) Truong-An Tran et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started